Related Experiment Video

Updated: Mar 19, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

12.3K

Relationship between platelet parameters and hepatic pathology in patients with chronic hepatitis B infection - a

Ye Pan1, Aikeremujiang Muheremu2, Xiaolu Wu1

  • 1Department of Infectious Diseases, The First Affiliated Hospital of Xiamen University, Xiamen, China.

The Journal of International Medical Research
|June 23, 2016
PubMed

Insights

Platelet parameters like platelet count (PLT) and platelet distribution width (PDW) correlate with liver inflammation and fibrosis in chronic hepatitis B virus (CHB) infection. These simple blood tests can help assess liver damage in CHB patients.

Area of Science:

  • Hepatology
  • Hematology
  • Virology

Background:

  • Chronic hepatitis B virus (CHB) infection is a significant global health concern.
  • Liver inflammation and fibrosis are key indicators of CHB progression and prognosis.
  • Accurate assessment of liver damage is crucial for effective patient management.

Purpose of the Study:

  • To investigate the association between routinely measured platelet parameters and liver inflammation and fibrosis in CHB patients.
  • To determine if platelet count (PLT), platelet distribution width (PDW), and mean platelet volume (MPV) can serve as biomarkers for liver disease severity.

Main Methods:

  • Retrospective analysis of 677 patients with liver biopsy-confirmed CHB.
  • Histopathological assessment of liver tissue for inflammation and fibrosis grading.
  • Analysis of platelet parameters (PLT, PDW, MPV) from routine blood tests.
  • Multiple linear regression models to evaluate relationships between platelet parameters and liver disease.

Main Results:

  • Platelet count (PLT) and platelet distribution width (PDW) explained 20.5% of the variance in liver inflammation.
  • PLT and PDW explained 18.4% of the variance in liver fibrosis.
  • These findings highlight a significant correlation between specific platelet indices and liver pathology.

Conclusions:

  • Platelet parameters, specifically PLT and PDW, offer valuable insights into the degree of hepatic inflammation and fibrosis in CHB.
  • Routine platelet measurements may serve as a non-invasive tool to aid in the assessment of liver disease severity in CHB patients.
Abstract

Keywords:
Hepatitis Bchronic hepatitiscorrelationhistologyplatelet

More Related Videos

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.1K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.3K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
324
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
6
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
278
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.5K
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
651